CD8A and melanoma: Another IMC study quantifying the expression of 35 protein markers in 67 pre-treatment melanomas, demonstrated that the abundance of proliferating antigen-experienced cytotoxic T cells (CD8+CD45RO+Ki67+) and their proximity to melanoma cells were associated with positive response to ICIs (32).